Thursday, October 29, 2009

United Nations Condemns America's Embargo on Cuba

For once, I happen to agree with the United Nations and its condemnation of the American embargo against Cuba. This Cuban embargo law is outdated (47 years and counting) and should be rescinded immediately. If we have dealings with China, Saudi Arabia and Vietnam, then we should have dealings with one of the closest nations to our borders. As an alleged socialist regime, I would have expected this President's administration to have eliminated this embargo long ago. I guess the current power holders value Florida and do not want to upset the anti-Castro crowd.

The assembly today voted 187-3 in opposition to the embargo, with only Israel and the Pacific island nation of Palau siding with the US, as they did last year. The annual diplomatic ritual had extra resonance this year because of the slight thaw in Washington-Havana relations.

Where in the world is Palau? Without taking a Scroogle cheat, I would say it is an island or atoll somewhere in the South Pacific.

Cuba's foreign minister, Bruno Rodriguez, told the meeting in New York that the embargo had cost the island tens of billions of dollars and denied medical care to children. "The blockade is an uncultured act of arrogance."

Source: The Guardian

Robins Can See the Earth's Magnetic Field!


Holy super abilities, Batman, robins can see the Earth's magnetic field. From animals that can change colors, run at ridiculous or lift heavy things, the whole animal kingdom is a like being in the Marvel Universe where everyone has some crazy superpower. Humans have super intelligence. Whales have enormous girth and size. Ants have tremendous numbers...And robins...well, robins can see the Earth's magnetic field!

The researchers, led by Dr Henrik Mouritsen from the University of Oldenburg, wrote in the journal Nature: ''The results of the present study ... specifically suggest that cluster N of European robins is an essential part of a circuit processing light-dependent magnetic compass information for night-time orientation.

''The exact role of cluster N within this circuit has not been determined, but the present results raise the distinct possibility that this part of the visual system enables birds to 'see' magnetic compass information.''

Source: London Telegraph

Image Source (pictured above - an American robin): Sujit Kumar



Wednesday, October 28, 2009

FBI Equates Paintball Activities to Al-Qaeda and Terrorism!


How many vague descriptions can one document have? If you do paintball, then you may be considered a potential terrorist by the FBI. I would imagine that many people would be considered suspects or suspicious under this document. After an exhaustive list of different things showing why someone would be suspicious by being different from the norm, the document further says at the end that someone is not suspicious just because he/she is different.



Tuesday, October 27, 2009

Obama Daughters Get H1N1 "Swine Flu" Shots (President Will Wait)

If I was the author of a blog that focuses on conspiracy theories, then I would want to know:

(1) Is there real time video of the Obama daughters getting the vaccine injections?
(2) Have the syringes used for the Obama daughter vaccines been tested to confirm that actual H1N1 "swine flu" vaccines were injected into them?

Oh wait, I do write a blog that focuses on conspiracy theories! Click the link below for the full details on Malia and Sasha getting the vaccine!

The Associated Press: Obama girls get swine flu shots, Obama will wait

DARPA Seeks to Build Broadband Internet for Low Earth Orbit Spacecraft by 2012-2013 (Request for Information)

Just in case, you have some information or technology about extra-planetary networking communications that DARPA might desire, you can submit your information for consideration to create a new Space 'Net.

###

Request for Information - Persistent Broadband Ground Connectivity for Spacecraft in Low Earth Orbit


Solicitation Number: DARPA-SN-10-02
Agency: Other Defense Agencies
Office: Defense Advanced Research Projects Agency
Location: Contracts Management Office
Notice Type: Special Notice
Posted Date: October 22, 2009
Response Date: Nov 05, 2009 5:00 pm Eastern
Archiving Policy: Automatic, 15 days after response date
Archive Date: November 20, 2009
Original Set Aside: N/A
Set Aside: N/A
Classification Code: A -- Research & Development
NAICS Code: 541 -- Professional, Scientific, and Technical Services/541712 -- Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Solicitation Number: DARPA-SN-10-02
Notice Type: Special Notice
Synopsis: Added: Oct 22, 2009 11:48 am

The Defense Advanced Research Project Agency's (DARPA's) Tactical Technology Office (TTO) is requesting information on possible approaches to providing persistent, low-latency, broadband data communications between spacecraft in low earth orbit (LEO) and the ground that can be in operational use by 2012-2013. DARPA's interest is in identifying end-to-end solutions that can provide 24/7 or near-24/7 two-way connection availability at latencies and bandwidth that are commensurate with performing telemetry, real-time control, sharing of network resources, and data exfiltration for a wide array of mission payloads.

Please consult the list of document viewers if you cannot open a file.
Persistent Broadband Ground Connectivity for Spacecraft in Low Earth Orbit RFI
Type: Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label: Persistent Broadband Ground Connectivity for Spacecraft in Low Earth Orbit RFI
Posted Date: October 22, 2009
Persistent Broadband in LEO RFI (10-22-09).pdf (82.85 Kb)
Description: Persistent Broadband Ground Connectivity for Spacecraft in Low Earth Orbit Request for Information

Contracting Office Address:
3701 North Fairfax Drive
Arlington, Virginia 22203-1714
Primary Point of Contact.:
Paul Eremenko
Program Manager
DARPA-SN-10-02@darpa.mil

All Files

Persistent Broadband Ground Connectivity for Spacecraft in Low Earth Orbit RFI Download compressed package in Zip format..
Oct 22, 2009
Persistent Broadband in LEO RFI (10-22-09).pdf

Opportunity History

* Original Synopsis
Oct 22, 2009
11:48 am

Missouri Suspends Thimerosal (Mercury) Ban in H1N1 "Swine Flu" Vaccines for Pregnant Women and Young Children

For Immediate Release:
Oct. 22, 2009

Contact:
Kit Wagar
Office of Public Information
573-751-6062

State health department issues exemption for flu vaccine
Action gives pregnant women and families of young children access to H1N1 vaccine

Missouri’s top public health official granted an exemption Thursday to allow pregnant women and parents of children less than three years old to choose whether to receive flu vaccine containing a mercury-based preservative.

Margaret Donnelly, director of the Department of Health and Senior Services, determined that a shortage of preservative-free vaccine was preventing pregnant women and young children from obtaining the new H1N1 vaccine.

Donnelly’s action temporarily sets aside a statute that prohibited pregnant women and children under three from receiving vaccine with this preservative.

The statute also allows the health director to set aside the ban in certain circumstances, including a pandemic or a shortage of vaccine. The waiver will remain in effect until the shortage no longer exists.

“The H1N1 flu is now widespread throughout Missouri,” Donnelly said. “We know that pregnant women and young children are the most susceptible to this illness. But delays in vaccine production have created a situation where the most vulnerable people were left without vaccine protection.”

Donnelly urged women and the parents of young children to consult their health care provider to determine whether any vaccine is appropriate for them.

Under the exemption, pregnant women and families of children younger than three years old will be able to decide whether to receive vaccines that contain small traces of mercury-based preservative.

####

Novartis Denies Problems with Celtura H1N1 "Swine Flu" Vaccine in Switzerland!

I cannot seem to find many other sources for this story nor can I find a lot of information about Celtura aside from what I have previously posted. Apparently, Novartis was facing hurdles getting Celtura approved by the Swiss, but Novartis denies the claim.

Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.

The vaccine, branded as Celtura, is produced by a technique using cell cultures from dog kidneys, allowing more rapid production than by the more classical method using chicken eggs, according to the company.


Citing anonymous sources close to the case, the Swiss daily Tages-Anzeiger reported on Saturday that the Swiss authority overseeing medicines and therapeutical products, Swissmedic, had found bacterial contamination in test batches of Celtura.

Source: Khaleej Times Online


Monday, October 26, 2009

U.S. Air Force Micro Air Vehicle (MAVs) Drones (a/k/a "Bugbots")


In case your corporate overload banker (i.e., the corporate creditor to whom you owe thousands) needs to find you in a crowded urban environment, it can send these bugbots based on the GPS information provided in your census or other electronic profile. Once the bugbot locks in on your position, there is no escape! If the government ever starts giving creditors tax breaks when their respective debtors die, then watch out, these MAVs will be sent into action!


Health Study Links Mobile Cell Phone Use to Four (4) Kinds of Cancer


Anyone who has ever had a satellite television system and a smart mobile phone will realize that these phones send off signals that will disrupt the satellite system. Because the human brain is an organic computer, there is no telling how the brain's electrical signals are disrupted when a phone is transmitting its high frequencies during calls. A recent study says that excessive mobile phone use can be linked to cancer.

A major international health study has shown that excessive mobile phone use can be linked to four different kinds of cancer.

The research, which has taken 10 years and cost £20million, found that heavy mobile users suffered up to 50 per cent more tumours.

Scientists now say there is a "significantly increased risk" of people developing three different kinds of brain tumour and one of the salivary gland. News of the findings, which are to be published within the next eight weeks, has led to calls for mobiles to carry health warnings.


Source: London Mirror

Image Source: David Dees


Another Young Woman Possibly Crippled by GARDASIL® Vaccine!



This is so tragic. I feel sorry for this woman! The toxic ingredients in vaccines need to be investigated thoroughly! Too many people have been crippled and/or killed!



Is Chicago About to Lease Its Water System to Foreign Corporations?

Carbon, water, oxygen and sunlight. The basic building blocks of life. Al Gore is trying to tax the carbon cycle through a global cap and trade system. The chemtrails are blocking sunlight resulting in less energy reaching the earth. The oxygen is all polluted and forests are being clear cut worldwide reducing overall oxygen levels. All that remains is our water.

Whether it is poisoning it with toxic fluoride or simply just selling it to the highest bidder like Homer Glen, Illinois, water is 25% of the life cycle and Mayor Daley is thinking about leasing Chicago's to third party interests.

The new boss could charge whatever they want for water, CBS 2's Roseanne Tellez reports.

Could it happen here in Chicago? It already has nearby. Homer Glen in Will County relies on Lake Michigan water, but the supply comes from a German-owned firm. Locals say there's a lot more than water going down the drain.

You can watch the video news report by clicking this sentence.

Source: CBS-2 Chicago


School Gives H1N1 Vaccine to Child Against Parents' Wishes!




Sunday, October 25, 2009

Energy Experts Say United States Needs "Independent" Energy Council Patterned After Council on Foreign Relations

More administration, paid government positions and bureaucrats! The report released by Sandia National Laboratories and the University of California, San Diego (UCSD) Sustainability Solutions Institute (SSI) says the United States needs to establish some type of energy council for energy issues similar to the Council on Foreign Relations for foreign issues.

Create a distinguished, high-level independent council, patterned after the Council on Foreign Relations, that could act as a forum for analyzing and communicating critical issues to energy policy makers and the public. (page 7 of report).

If you want to read the full PDF report called Perspectives on Energy Policy, then click this sentence
.

I say hogwash! We already have a Department of Energy (which also happens to fund the organization that published this report). Why do we need a private consortium of energy "experts" like Al Gore and others lobbying the government to fund these experts' corporate for-profit ventures?

The United States needs a high-level independent council to analyze and explain critical energy issues, energy experts said.

A group of 27 experts from U.S. universities, the government and business make that recommendation in a new report called Perspectives on Energy Policy.


Ensuring energy for the future means acting now to help policymakers and the public understand effective solutions, Les Shephard, vice president of Sandia National Laboratories, said in a release Friday.

###

Public release date: 22-Oct-2009

Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
'Perspectives on Energy Policy' report now available

Energy leaders call for independent energy council, recommend outcomes and values-based policies

LIVERMORE, Calif. — The United States should create a high-level independent council to analyze and communicate critical issues to energy policymakers and the public, a group of 27 leaders in academia, government, and the private sector recommends in a new report.

The report, "Perspectives on Energy Policy: Security, Economics, and the Environment," is the result of a workshop convened by Sandia National Laboratories and the University of California, San Diego (UCSD) Sustainability Solutions Institute (SSI) in March.

The report also recommends that policymakers focus their attention on outcomes and values rather than on mandating specific technical solutions

"At no time in our nation's history have the challenges associated with securing America's energy future been so paramount and the need to develop systems solutions so critical if we are to find effective solutions to address the energy–climate nexus," said Les Shephard, Sandia's vice president for energy, security and defense technologies. "To assure this future we must find more effective approaches to fully couple the energy policy community with the science and technology community to provide informed policy decisions that will benefit the global community. This report is one small but important step in moving in this direction."

Other recommendations for action noted in the report:

* Develop educational curricula that address energy and sustainability, suitable for all levels, that will accelerate the development of next-generation technologies and workforce
* Develop tangible messages to engage the broader public to think about their energy choices and help citizens make informed decisions
* Conduct an assessment of the nation's energy security status, comparable to those already executed for environmental and economic security

The high-level council recommended in the report would be patterned after the Council on Foreign Relations and provide an in­dependent venue for addressing energy policy op­tions that help deepen the nation's understand­ing of how security, economics, and environmental considerations interact in developing energy policy decisions.

In addition to the workshop organizers, participants represented a variety of organizations, including the automotive industry, distinguished universities, national laboratories, and "think tanks." The event brought together leaders from diverse backgrounds to identify promising areas for energy policy, based on understanding the issues, assumptions, and priorities from three intersecting perspectives of energy policy: security, economics, and the environment.

###

The full report, as well as an Executive Summary, are now available online at http://www.sandia.gov/news/publications/white-papers/index.html.

Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy's National Nuclear Security Administration. With main facilities in Albuquerque, N.M., and Livermore, Calif., Sandia has major R&D responsibilities in national security, energy and environmental technologies, and economic competitiveness.

Peramivir Injection Authorized by FDA for Emergency Use in H1N1 "Swine Flu" Pandemic

When it comes to the flu and the government, a person in the United States has either had the flu or he/she is expected to get it soon. If a person has the flu, then he/she is expected to take an antiviral drug such as Tamiflu. If someone does not yet have the flu, then he/she is expected to take one of several H1N1 vaccines that contains toxic ingredients.

Adding to the antiviral drug mix for people who are infected by the H1N1 "swine flu" is an injection called Peramivir by BioCryst Pharmaceuticals, Inc. Please note that Peramivir is UNAPPROVED for use and only an emergency declaration allows its use.

Commonly reported adverse events in Peramivir IV clinical trials were diarrhea, nausea, vomiting, and neutropenia. Additional adverse events associated with the drug, some of which may be serious, may become apparent with more widespread use.

Although not observed in clinical trial data available to date Peramivir IV may be associated with rare cases of anaphylaxis and serious skin reactions and a variety of neurologic and behavioral symptoms that have been reported with other neuraminidase inhibitors.




Read the MAIN Peramivir injection fact sheet by clicking this sentence.

Read the Patient Peramivir fact sheet by clicking this sentence.

Emergency Use Authorization Granted For BioCryst's Peramivir

BIRMINGHAM, Ala., Oct. 23 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

Specifically, i.v. peramivir is authorized only for hospitalized adult and pediatric patients for whom therapy with an i.v. drug is clinically appropriate, based on one or more of the following reasons:


1. the patient is not responding to either oral or inhaled anti-viral therapy, or


2. when drug delivery by a route other than an intravenous route -- e.g., enteral (absorbed by the intestines) or inhaled -- is not expected to be dependable or feasible;


3. for adults only, when the clinician judges i.v. therapy is appropriate due to other circumstances.


Additional information regarding the peramivir EUA is available on the Web at:


www.cdc.gov/h1n1/eua


In advance of any U.S. Government order that may come from the ongoing request for proposal (RFP) negotiations, BioCryst has donated and transferred to the Department of Health and Human Services (HHS) an initial supply sufficient for 1,200 courses of i.v. peramivir 600 mg once-daily for five days. This transfer was made under the development contract with HHS to allow doctors and patients near-term access to the drug, and is separate from the RFP process.


"The issuance of this EUA is important because it makes peramivir a treatment option for physicians in the U.S. during the ongoing influenza health emergency," said Jon P. Stonehouse, Chief Executive Officer at BioCryst. "BioCryst has worked with HHS to enable the Government to rapidly deploy an initial supply of peramivir, and we are prepared to deliver more."


To prepare for peramivir orders that BioCryst may receive from the U.S. or other governments during this pandemic emergency, BioCryst is completing production of approximately 130,000 courses of i.v. peramivir and is prepared to make more, if required.


About Peramivir


Peramivir is an anti-viral agent that was discovered by BioCryst which inhibits the interactions of influenza neuraminidase, an enzyme which is critical to the spread of influenza within a host. In laboratory tests, peramivir has shown activity against pandemic H1N1 swine flu origin viral strains. Peramivir has been studied in patients with complicated and uncomplicated influenza. BioCryst's partner, Shionogi & Co., Ltd. is currently preparing to file for regulatory approval in Japan this year.


About BioCryst


BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor for cutaneous T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Limited validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's Web site at www.biocryst.com.


Forward-Looking Statements


This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that the U.S. government and ex-U.S. governments may choose not to issue a request for peramivir to treat influenza or such requests, if any, may not result in an order or such order, if any, may not be profitable for BioCryst; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that our product candidates may not receive required regulatory clearances from the FDA; that ongoing and future pre-clinical and clinical development may not have positive results; that we or our licensees may not be able to continue future development of our current and future development programs; that our development programs and partnerships may never result in future product, license or royalty payments being received by BioCryst; that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates; that our actual cash burn rate may not be consistent with our expectations; that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (filed November 28, 2008), Quarterly Reports on Form 10-Q, and current reports on Form 8-K, all of which identify important factors that could cause the actual results to differ materially from those contained in our projections and forward-looking statements.


SOURCE: BioCryst Pharmaceuticals, Inc.



U.S. Government Wants to Know Where the Veterans Are (Questionnaires to Follow)



This may merely be an administrative thing, but the Department of Veterans Affairs has sent out notice that it will be sending questionnaires to veterans and their families to get information about the veteran in question. Has any other veteran received a letter like this? Is it harmless or something more?

Source: Prison Planet Forums



Four (4) Deaths Linked to H1N1 "Swine Flu" Vaccine in Sweden

I wonder if there are any deaths linked to the H1N1 "swine flu" vaccine here in the United States, will it be reported? In Sweden, four (4) deaths are being linked to the H1N1 "swine flu" vaccine.

Health investigators are under more pressure as two elderly women are reported to have died, days after receiving the swine flu vaccine. It brings the total number of deaths linked to the vaccine in Sweden to four.

Source: The Local



Obama's Daughters Not Vaccinated Against H1N1 "Swine Flu"

President Obama's school age daughters have not been vaccinated against the H1N1 flu virus. White House Press Secretary Robert Gibbs says the vaccine is not available to them based on their risk.

Source: » Row 2, Seat 4 « FOXNews.com



Saturday, October 24, 2009

U.S. NORTHCOM Contracts with ClearCube Technology to Support Command-and-Control with Secure Workstations

This is more of an informational article about NORTHCOM's contracting with ClearCube Technology as opposed to any specific commentary, but you can read about the ClearCube Technology company by clicking this sentence.

U.S. company ClearCube announced it has been selected by NORTHCOM for its fiber optic connected blade workstations and user ports as part of an ongoing effort to reduce security threats at mission-critical personal computers

The ClearCube blade workstations, expected to be integrated at NORTHCOM's command-and-control center, is installed a secure data centers instead of on a computer desktop, which company officials say increases security.

Source: United Press International


Sheila Bair Delivers Special FDIC Video Message Commemorating 100+ Bank Failures This Year!



Madam Chairman Sheila Bair believes that all FDIC deposited monies under the specified limits will be 100% protected. However, Bair does not mention that the FDIC is broke! You can read the many previous articles on this blog by clicking this sentence. Even though the FDIC is backed by the full faith and credit of the United States government, the current government is saddled with debts and a huge FDIC bailout would further erode our economy.

Ms. Bair is trying way too hard to be convincing in this video. It reminds me of the movie "Airplane" when Leslie Nielsen was trying to convince the airplane passengers that everything was going smoothly with the flight. Fast forward to 4:43 below. I fully expected Sheila Bair's nose to start growing right before our eyes.




The End of the U.S. Dollar Possibly Confirmed? (Lazard Asset Management World Trust Fund Dumps The Dollar for Sterling)



Here is some more proof that the dollar is sliding. The Board of the prestigious Lazar Asset Management Fund has proposed dumping the dollar and replacing it with the Sterling.

***

LONDON--(BUSINESS WIRE)
October 23, 2009



Introduction

In the most recent report and accounts published by The World Trust Fund (the “Fund”), the Board referred to the possible change of currency in which the Fund’s shares are traded and a sub-division of the share capital, both of which would be expected to assist in the marketability of the Fund’s shares. The Board is pleased to announce today proposals to implement these changes, together with certain other proposed changes to the Fund’s benchmark and performance fee arrangements with the Fund’s investment manager, Lazard Asset Management LLC (“Lazard”). In summary, the proposals are to:

(i) change the currency in which the Fund’s shares are traded from US dollars to Sterling;

(ii) undertake a sub-division of the Fund’s share capital on the basis of 10 new ordinary shares for each existing ordinary share;

(iii) change the benchmark of the Fund to the MSCI All Countries World Index; and

(iv) increase the NAV on which the performance fee calculation is based ("Reference NAV") to reflect the underperformance of the Fund over the previous 12 months.

The proposed sub-division and change of benchmark are conditional upon the approval of shareholders and it is anticipated that a circular containing details of those proposals (“Circular”) and a notice of extraordinary general meeting (“EGM”) will be sent to shareholders following approval of the Circular by the Commission de Surveillance du Secteur Financier (“CSSF”). This approval is required as a consequence of the Fund being incorporated in Luxembourg.

Change of share trading currency and proposed sub-division

In response to comments from a number of shareholders and potential investors in the Fund about the liquidity of the Fund’s shares, the Board, having consulted with the Fund’s brokers, Arbuthnot Securities, believes that having a larger number of shares in issue with a lower share price than at present and changing the currency in which the shares are traded from US dollars to Sterling, should assist in improving the marketability and liquidity of the Fund’s shares and support the attraction and retention of a diverse shareholder base.

Change of share trading currency – the London Stock Exchange has confirmed that the currency in which the Fund’s shares are traded will change from US dollars to Sterling with effect from 8.00 am on Friday 30 October 2009.

Proposed sub-division – the Board intends to send a Circular to shareholders, following approval by the CSSF, to approve a resolution to sub-divide the ordinary shares of $2 each in the capital of the Fund so that shareholders will receive 10 new ordinary shares of $0.20 for each existing ordinary share of $2. The value of each shareholding will not be affected by the proposed sub-division. The new ordinary shares will, in all respects, rank pari passu with and, except for the difference in nominal value, be subject to the same rights and restrictions as the existing ordinary shares and, in particular, the holders of new ordinary shares will have the same voting rights, the same rights to participate in dividends or income of the Fund and the same rights on a liquidation of the Fund as holders of existing shares. There will be no increase in total share capital as a result of the sub-division, no new shares are being marketed or being made available to non-shareholders in whole or in part and no additional funds are being raised. An expected timetable of principal events in relation to the proposed sub-division will be set out in the Circular.

Proposed change of Benchmark

The Board announced in the Fund’s latest annual accounts that it had been discussing with Lazard a proposed change to the Fund’s benchmark from the MSCI World Index (“Benchmark”), which has no emerging market component, to the MSCI All Countries World Index which includes an emerging markets element (although at a smaller percentage than those investments in the Fund’s current portfolio). In light of the expectation that the Fund will be maintaining a material commitment to emerging markets, the Board has now decided that a change in benchmark would be desirable. The Board also believes that the proposed benchmark will improve transparency and align the Fund’s benchmark with that of its peers in the sector. The proposed change to the benchmark will be conditional upon the approval of both the CSSF and shareholders. Details of the resolution to be put to shareholders and of the EGM will be set out in the Circular, which will be despatched following approval by the CSSF.

Change to the performance fee arrangements

In the period from 31 March 2008 to 31 March 2009, the Fund’s NAV fell by 61.3%, underperforming the MSCI World Index, which fell by 44.0%. The Board has discussed this under performance with the Fund’s investment manager and Lazard has proposed an adjustment to the Reference NAV. The proposal involves increasing the Reference NAV from $17.66 to $25.57 for the period 31 March 2009 to 31 March 2011 to reflect the previous year’s under performance relative to the Benchmark. This will result in the investment manager only being entitled to the payment of a performance fee if there is out-performance relative to the Benchmark using the higher Reference NAV. Except for the raising of the Reference NAV, the performance fee will continue to be calculated in the same manner as described in the Fund's legal documentation. The Board believes that this adjustment will benefit shareholders while at the same time continuing to provide an incentive for the Fund’s investment manager to out-perform the Benchmark.
For more information contact:
Arbuthnot Securities Limited
Alastair Moreton / Hannah Pearce
020 7012 2000

Short Name: World Trust Fund
Category Code: CAR
Sequence Number: 201015
Time of Receipt (offset from UTC): 20091023T081339+0100

Source: AnnuityIQ; Business Wire